Xiaojiao Sun
Xueyuan Road 38
Haidian, 100191, China
Haidian, 100191, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Design and Synthesis of a Novel Covalent Dihydropteridinone Derivative as a Highly Potent and Orally Bioavailable PLK1 Inhibitor for the Treatment of Chronic Myeloid Leukemia.
Journal: Journal of medicinal chemistry
Published: June 30, 2026
Machine learning-based integrative analysis identifies CXCL13-driven tertiary lymphoid structures as favorable immune and prognostic features in osteosarcoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 27, 2025
An orally bioavailable pan-αv/α5β1 integrin antagonist prevents aggressive prostate cancer progression via suppressing both oncogenic signals and CD47-mediated immune escape.
Journal: Molecular cancer
Published: December 25, 2025
Structural insights into the specificity of adaptor proteins Dok5 and Dok6 Docking to Trk receptors.
Structural insights into the specificity of adaptor proteins Dok5 and Dok6 Docking to Trk receptors.
Journal: Cell communication and signaling : CCS
Published: December 05, 2025
Structure-Based Discovery of Quinazolin-2-amine Derivatives as Potent ROR1 Pseudokinase Inhibitors with In Vitro and In Vivo Efficacy against Triple-Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: July 30, 2025
Structure-Based Discovery of a Highly Selective, Oral Polo-Like Kinase 1 Inhibitor with Potent Antileukemic Activity.
Journal: Journal of medicinal chemistry
Published: February 18, 2025
Discovery of novel PI3KC2γ inhibitors with high potency, selectivity, and favorable pharmacokinetics for glycogen metabolism regulation.
Journal: European journal of medicinal chemistry
Published: January 17, 2025
Systematic Characterisation and Analysis of Lysyl Oxidase Family Members as Drivers of Tumour Progression and Multiple Drug Resistance.
Journal: Journal of cellular and molecular medicine
Published: October 23, 2024
Design, synthesis, and antitumor activity of NSDs inhibitors targeting lung squamous cell carcinoma.
Design, synthesis, and antitumor activity of NSDs inhibitors targeting lung squamous cell carcinoma.
Journal: European journal of medicinal chemistry
Published: August 05, 2024
Augmenting Chemokine CCL21 Enhances the Effectiveness of CTLA4 Blockade Immunotherapy for Head and Neck Squamous Carcinoma.
Journal: Molecular cancer therapeutics
Published: March 14, 2024
Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Cancer.
Journal: Advanced healthcare materials
Published: February 24, 2024
Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor-Associated Macrophage.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 10, 2024
Last Updated: 09/26/2026